ACTHX | NHMRX | ACTHX / NHMRX | |
Total Expense Ratio | 1.54 | 1.91 | 81% |
Annual Report Gross Expense Ratio | 1.54 | 1.91 | 81% |
Fund Existence | 39 years | 26 years | - |
Gain YTD | -2.484 | -3.588 | 69% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.25B | 14.5B | 50% |
Annual Yield % from dividends | 5.28 | 5.41 | 98% |
Returns for 1 year | 2.95 | 0.69 | 427% |
Returns for 3 years | 2.24 | 0.66 | 341% |
Returns for 5 years | 10.31 | 13.62 | 76% |
Returns for 10 years | 30.37 | 19.17 | 158% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BGPKX | 12.54 | 0.19 | +1.54% |
Baillie Gifford Developed EAFE All Cap K | |||
ARIOX | 10.60 | 0.10 | +0.95% |
Aristotle/Saul Global Eq I | |||
RDWBX | 10.58 | 0.07 | +0.67% |
American Funds Dvlpg Wld Gr&Inc R2 | |||
BMGAX | 30.70 | 0.19 | +0.62% |
BlackRock Mid-Cap Growth Equity Inv A | |||
SCSAX | 14.67 | 0.05 | +0.34% |
Allspring Common Stock A |